[Diagnostic and therapeutic features of invasive lobular carcinoma of the breast: a study of 30 cases].
Le carcinome lobulaire infiltrant du sein: à propos de 30 cas.
Invasive lobular carcinoma
epidemiology
prognosis
treatment
Journal
The Pan African medical journal
ISSN: 1937-8688
Titre abrégé: Pan Afr Med J
Pays: Uganda
ID NLM: 101517926
Informations de publication
Date de publication:
2019
2019
Historique:
received:
08
04
2019
accepted:
07
09
2019
entrez:
11
12
2019
pubmed:
11
12
2019
medline:
26
12
2019
Statut:
epublish
Résumé
Invasive lobular carcinoma (ILC) of the breast accounts for 5-15% of breast cancers. It is classified as the second most frequent histological type after non-specific invasive cancer (NSIC) and its prevalence has seen a marked increase. Clinical and radiological diagnosis is difficult. Usually, this cancer develops bilaterally and more slowly than non-specific invasive cancer, with best prognostic factors. The purpose of our study was to describe in detail the clinical, radiological, therapeutic and prognostic features of invasive lobular carcinoma. We conducted a retrospective descriptive study of 30 cases with ILC of the breast whose data were collected at the Center of Maternity and Neonatology, Monastir over a period of 10 years. The prevalence of ILC was 5.2%. The average age of patients was 53.43 years. Ten percent of patients had a personal history of benign mastopathies, 6.66% had a personal history of breast cancer and 3.33% had a family history of breast cancer. Late-stage diagnosis was made in 18 cases. Bifocal mass was found in 5 patients, multifocal mass in 4 patients and bilateral mass in 3 patients. Only one patient had liver metastasis at the time of diagnosis. Radical mastectomy (Patey) was immediately performed in 63.33% of patients. Anatomo-pathological examination showed multifocal lesions in 44.80% of cases. Lymph node dissection was satisfactory in 21 patients; 28 patients (93.33%) underwent radiotherapy and adjuvant hormonal therapy. Five-year overall survival was 77.3%.
Identifiants
pubmed: 31819786
doi: 10.11604/pamj.2019.34.70.18780
pii: PAMJ-34-70
pmc: PMC6884720
doi:
Types de publication
Journal Article
Langues
fre
Sous-ensembles de citation
IM
Pagination
70Informations de copyright
© Bergaoui Haïfa et al.
Déclaration de conflit d'intérêts
Les auteurs ne déclarent aucun conflit d’intérêts.
Références
Bull Cancer. 1997 Dec;84(12):1101-7
pubmed: 9587361
Radiother Oncol. 2009 Apr;91(1):49-53
pubmed: 18950883
Clin Cancer Res. 2006 Nov 15;12(22):6652-62
pubmed: 17121884
J Radiol. 2005 Nov;86(11):1649-57
pubmed: 16269978
Radiographics. 2009 Jan-Feb;29(1):165-76
pubmed: 19168843
Breast Dis. 2008-2009;30:3-8
pubmed: 19850989
Ann Surg Oncol. 2010 Jul;17(7):1862-9
pubmed: 20162457
Lancet Oncol. 2006 Nov;7(11):910-8
pubmed: 17081916
Fam Cancer. 2016 Apr;15(2):215-9
pubmed: 26759166
J Med Imaging Radiat Oncol. 2014 Feb;58(1):1-10
pubmed: 24529050
Br J Cancer. 2005 Oct 31;93(9):1046-52
pubmed: 16175185
AJR Am J Roentgenol. 1999 Feb;172(2):325-30
pubmed: 9930776
Ann Oncol. 2000 Oct;11(10):1255-62
pubmed: 11106113
J Clin Ultrasound. 2004 Sep;32(7):323-32
pubmed: 15293298
Diagn Pathol. 2010 Jun 15;5:36
pubmed: 20550696
Int J Cancer. 2003 Oct 10;106(6):961-4
pubmed: 12918077
Cancer Epidemiol Biomarkers Prev. 2012 Jan;21(1):134-47
pubmed: 22144499
JAMA. 2003 Mar 19;289(11):1421-4
pubmed: 12636465